Total Payments
$84,791
2024 Payments
$28.88
Companies
9
Transactions
78
Medicare Patients
5,325
Medicare Billing
$1.2M
Payment Breakdown by Category
Consulting$79,602 (93.9%)
Other$2,500 (2.9%)
Food & Beverage$1,445 (1.7%)
Travel$1,209 (1.4%)
Education$34.79 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $79,602 | 40 | 93.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 2.9% |
| Food and Beverage | $1,445 | 29 | 1.7% |
| Travel and Lodging | $1,209 | 2 | 1.4% |
| Education | $34.79 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $71,174 | 36 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,428 | 4 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, INC. | $4,223 | 8 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $656.86 | 15 | $0 (2024) |
| Allergan Inc. | $146.37 | 4 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $90.14 | 7 | $0 (2022) |
| Vapotherm Inc | $33.77 | 2 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $22.02 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $16.74 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.88 | 1 | ACADIA Pharmaceuticals Inc ($28.88) |
| 2023 | $497.33 | 14 | ACADIA Pharmaceuticals Inc ($458.57) |
| 2022 | $198.13 | 4 | ACADIA Pharmaceuticals Inc ($169.41) |
| 2021 | $11.27 | 1 | Avanir Pharmaceuticals, Inc. ($11.27) |
| 2020 | $8,484 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($8,428) |
| 2019 | $24,615 | 15 | Shire North American Group Inc ($24,484) |
| 2018 | $28,339 | 21 | Shire North American Group Inc ($24,084) |
| 2017 | $22,616 | 14 | Shire North American Group Inc ($22,606) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/12/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $9.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/30/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $9.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/30/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $1.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/09/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/09/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $1.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/29/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/15/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/11/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: NEUROLOGY | ||||||
| 04/20/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $76.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/20/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Neuropsychiatry | ||||||
| 03/30/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/30/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/24/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/24/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/29/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $44.41 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/09/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/21/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/21/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/28/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/02/2020 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Respiratory | ||||||
| 11/12/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/07/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,107.00 | General |
| 03/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,107.00 | General |
| 02/27/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,627 | 4,689 | $980,304 | $350,275 |
| 2022 | 14 | 1,889 | 7,505 | $1.7M | $515,108 |
| 2021 | 5 | 605 | 1,133 | $423,528 | $93,677 |
| 2020 | 12 | 1,204 | 2,513 | $2.4M | $226,122 |
Total Patients
5,325
Total Services
15,840
Medicare Billing
$1.2M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 268 | 1,535 | $288,459 | $120,584 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 749 | $187,754 | $54,363 | 29.0% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 127 | 293 | $79,216 | $32,685 | 41.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 178 | 521 | $80,981 | $28,503 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 90 | 226 | $95,910 | $24,160 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 132 | 407 | $71,441 | $19,762 | 27.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 71 | 196 | $37,543 | $15,273 | 40.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 124 | 196 | $28,518 | $11,852 | 41.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 43 | 68 | $18,472 | $7,430 | 40.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 40 | 47 | $15,638 | $5,984 | 38.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 37 | 38 | $12,132 | $5,181 | 42.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 80 | 109 | $11,227 | $5,116 | 45.6% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 36 | $8,028 | $3,602 | 44.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $8,866 | $2,988 | 33.7% |
| 99291 | Critical care, first 30-74 minutes | Office | 2023 | 12 | 15 | $7,649 | $2,899 | 37.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 36 | 52 | $8,256 | $2,842 | 34.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 37 | 46 | $7,635 | $2,651 | 34.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 52 | 57 | $5,301 | $2,002 | 37.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 23 | $2,878 | $905.97 | 31.5% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 16 | $1,776 | $848.35 | 47.8% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 13 | 14 | $1,202 | $359.20 | 29.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 22 | $1,422 | $284.83 | 20.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 172 | 1,894 | $420,570 | $130,196 | 31.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 130 | 1,027 | $227,712 | $70,297 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 631 | $167,846 | $47,959 | 28.6% |
About Dr. Gregory Baird, MD
Dr. Gregory Baird, MD is a Hospitalist healthcare provider based in South Jordan, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1902148133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Baird, MD has received a total of $84,791 in payments from pharmaceutical and medical device companies, with $28.88 received in 2024. These payments were reported across 78 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($79,602).
As a Medicare-enrolled provider, Baird has provided services to 5,325 Medicare beneficiaries, totaling 15,840 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties General Practice
- Location South Jordan, UT
- Active Since 03/26/2013
- Last Updated 11/19/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902148133
Products in Payments
- BEVYXXA (Drug) $4,107
- NUPLAZID (Drug) $656.86
- DALVANCE (Drug) $146.37
- ANDEXXA (Drug) $116.01
- NUEDEXTA (Drug) $66.89
- Nuedexta (Drug) $39.99
- Precision Flow (Device) $33.77
- INGREZZA (Drug) $22.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.